EUCTR2012-002622-75-DKActive, not recruitingPhase 1
ymphatic dysfunction as a cause of calcium channel blocker oedema
Vibeke Hjortdal0 sites6 target enrollmentStarted: May 21, 2013Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 6
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- Male
Inclusion Criteria
- •18-35 years old
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 6
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •hypotension, orthostatic hypotension, angina pectoris, previous acute myocardial infarction, previous gastrointestinal bleeding, currently in treatment of any type of calcium channel blocker or allergy against anything in the tablets.
Investigators
Similar Trials
Active, not recruiting
Phase 1
Defective lymphatic vasculature as a cause of fluid retention by calcium channel blocker therapy in women after menopause.Calcium channel antagonist induced peripheral edema in post-menopausal women. We hypothesize that this condition is partly due to impaired lymphatic function in these patients.MedDRA version: 18.0Level: LLTClassification code 10067033Term: Drug side effectSystem Organ Class: 100000004867MedDRA version: 18.0Level: LLTClassification code 10034570Term: Peripheral edemaSystem Organ Class: 100000004867EUCTR2015-001761-11-DKThe Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital16
Completed
Phase 4
Therapeutic effects of L/N type calcium channel blocker cilnidipine and L type calcium channel blockers on hypertensive patients with chronic kidney diseaseHypertension, Chronic kidney diseaseJPRN-UMIN000001593Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine60
Unknown
Not Applicable
Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC)NSCLCNCT02283021Hadassah Medical Organization200
Completed
Not Applicable
The comparison of the effect of calcium channel blockers on blood pressure lowering and presevation of renal function in refractory hypertensive patientsrefractory hypertensionJPRN-UMIN000004909St. Marianna University School of Medicine30
Recruiting
Not Applicable
Effects of combination drugs of calcium channel blockers and angiotensin II receptor blockers on blood pressure, lipid profile, and glucose metabolism in hypertensive patients with glucose intolerance.HypertensionJPRN-UMIN000006651Juntendo University School of Medicine, Department of Cardiovascular Medicine40